ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,172,538 | +43.7% | 83,747 | +13.9% | 4.95% | +22.6% |
Q2 2023 | $28,655,288 | +4.6% | 73,526 | 0.0% | 4.04% | -14.2% |
Q1 2023 | $27,394,317 | -1.6% | 73,526 | 0.0% | 4.71% | +6.6% |
Q4 2022 | $27,853,855 | +7.3% | 73,526 | 0.0% | 4.42% | -3.2% |
Q3 2022 | $25,958,000 | -6.8% | 73,526 | 0.0% | 4.56% | -28.4% |
Q2 2022 | $27,858,000 | -28.9% | 73,526 | -40.8% | 6.38% | -31.2% |
Q1 2022 | $39,175,000 | +42.2% | 124,244 | +58.0% | 9.26% | +2.0% |
Q4 2021 | $27,540,000 | +55.5% | 78,644 | +34.1% | 9.08% | +41.0% |
Q3 2021 | $17,710,000 | -14.9% | 58,644 | -15.2% | 6.44% | -24.7% |
Q2 2021 | $20,817,000 | +46.9% | 69,144 | +34.4% | 8.56% | +43.3% |
Q1 2021 | $14,169,000 | -3.5% | 51,450 | +3.0% | 5.97% | +13.7% |
Q4 2020 | $14,690,000 | +12.0% | 49,950 | 0.0% | 5.25% | -5.4% |
Q3 2020 | $13,113,000 | +15.4% | 49,950 | -1.0% | 5.55% | +9.6% |
Q2 2020 | $11,363,000 | +12.5% | 50,450 | -34.2% | 5.07% | -17.2% |
Q1 2020 | $10,096,000 | -19.5% | 76,638 | -1.9% | 6.12% | -19.5% |
Q4 2019 | $12,543,000 | – | 78,138 | – | 7.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |